title: Alcohol withdrawal-induced change in lipoprotein(a): association with the growth hormone/insulin-like growth factor-I (IGF-I)/IGF-binding protein-1 (IGFBP-1) axis.
abstract: Lipoprotein(a) [Lp(a)] is an important risk factor for cardiovascular disease. Alcohol is one of the few nongenetic factors that lower Lp(a) levels, but the metabolic mechanisms of this action are unknown. Alcohol inhibits the growth hormone (GH)/insulin-like growth factor-I (IGF-I) axis. Alcohol might also affect IGF-binding protein-1 (IGFBP-1), which is an acute inhibitor of IGF-I. We studied how alcohol withdrawal affects Lp(a) levels and the GH/IGF-I/IGFBP-1 axis. Male alcohol abusers (n=27; 20 to 64 years old) were monitored immediately after alcohol withdrawal for 4 days. Twenty-six healthy men, mainly moderate drinkers, served as control subjects. Fasting blood samples were drawn to determine Lp(a), IGF-I, and IGFBP-1 (by ELISA, RIA, and immunoenzymometric assay, respectively). Nocturnal (12 hours) urine collection was performed in 9 alcoholics and 11 control subjects for GH analyses (RIA). The groups were similar in age and body mass index. Lp(a), GH, and IGF-I tended to be lower and IGFBP-1 higher in the alcoholics immediately after alcohol withdrawal than in the control subjects. During the 4-day observation in alcoholics, Lp(a) levels increased by 64% and IGF-I levels by 41%, whereas IGFBP-1 levels decreased by 59% (P<.001 after ANOVA for all comparisons). Urinary GH levels tended to decline. The increase in Lp(a) correlated inversely with the changes in IGFBP-1 (r= -.63, P<.001, n=27) and GH (r=-.70, P<.05, n=9), but not with IGF-I. In multiple regression analysis, the main predictors for the increase in Lp(a) were IGFBP-1 and urinary GH. In conclusion, alcohol withdrawal induces interrelated and potentially atherogenic changes in Lp(a) and IGFBP-1 levels.
authors.affiliation: Department of Internal Medicine and Biocenter Oulu, University of Oulu, Finland. marita.paassilta@oulu.fi
authors.forename: M
authors.initials: M
authors.lastname: Paassilta
authors.forename: K
authors.initials: K
authors.lastname: Kervinen
authors.forename: M
authors.initials: M
authors.lastname: Linnaluoto
authors.forename: Y A
authors.initials: YA
authors.lastname: Kesäniemi
mesh_terms: D000328:Adult; D000437:Alcoholism / Q000628:therapy; D015992:Body Mass Index; D000431:Ethanol / Q000009:adverse effects*; D019382:Human Growth Hormone / Q000652:urine*; D006801:Humans; D018970:Insulin-Like Growth Factor Binding Protein 1 / Q000097:blood*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis; D013375:Substance Withdrawal Syndrome / Q000097:blood*
chemical_list: D018970:Insulin-Like Growth Factor Binding Protein 1; D017270:Lipoprotein(a); D019382:Human Growth Hormone; D000431:Ethanol; D007334:Insulin-Like Growth Factor I